Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bioxcel Therapeutics Inc (NQ: BTAI ) 0.6029 +0.0686 (+12.84%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bioxcel Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 Next > BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 06, 2024 BTAI stock results show that BioXcel Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study June 25, 2024 BioXcel Therapeutics shares topline results from an Igalmi (dexmedetomidine) sublingual film study. The 180 mcg dose demonstrated favorable safety and efficacy in reducing agitation symptoms. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 25, 2024 Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning! Via InvestorPlace BTAI Stock Earnings: BioXcel Therapeutics Misses EPS, Beats Revenue for Q1 2024 May 09, 2024 BTAI stock results show that BioXcel Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace BioXcel Therapeutics's Earnings Outlook March 11, 2024 Via Benzinga Why BioXcel Therapeutics Shares Are Falling Today February 09, 2024 BioXcel Therapeutics sees a dip in shares as it launches a $60 million public offering to fund clinical trials and corporate needs. Via Benzinga AI Surge Has Ended: All 7 AI Stock Categories Declined This Week April 13, 2024 From no AI category losses in February, to 3 drops in March - now all 7 fell this week, clearly indicating that that the surge in AI stock prices that began back on October 31st is, indeed, over. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Six Of Seven AI Stock Categories Increased This Week March 23, 2024 All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial... Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence 7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode March 07, 2024 Bullish speculators could have their opportunity to blow up the bears with these short-squeeze stocks to buy. Via InvestorPlace AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD March 04, 2024 Grand View Research says the global Via Talk Markets Earnings Scheduled For March 12, 2024 March 12, 2024 Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session February 27, 2024 Via Benzinga AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics February 19, 2024 The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence 12 Health Care Stocks Moving In Wednesday's Intraday Session February 14, 2024 Via Benzinga Why BioXcel Therapeutics Shares Are Rising Tuesday February 13, 2024 BioXcel Therapeutics shares surge 25.1% as the company terminates its proposed public offering and shifts focus to upcoming FDA meeting and Phase 3 trial. Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's Intraday Session February 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session February 12, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session February 09, 2024 Via Benzinga Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session February 09, 2024 Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session February 09, 2024 Via Benzinga Why Is CleanSpark (CLSK) Stock Up 27% Today? February 09, 2024 CleanSpark stock is rising higher on Friday as investors in CLSK shares celebrate the company's positive Q1 earnings report. Via InvestorPlace S&P 500 Tops 5,000; PepsiCo Posts Upbeat Earnings February 09, 2024 U.S. stocks traded mixed this morning, with the S&P 500 topping the 5,000 mark on Friday. Following the market opening Friday, the Dow traded down 0.05% to 38,706.33 while the NASDAQ rose 0.32% to... Via Benzinga Topics Stocks Exposures US Equities Why Is BioXcel Therapeutics (BTAI) Stock Down 26% Today? February 09, 2024 BioXcel Therapeutics stock is falling on Friday after the company announced plans for a proposed public offering of BTAI shares. Via InvestorPlace 12 Health Care Stocks Moving In Friday's Pre-Market Session February 09, 2024 Via Benzinga Why Cloudflare Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket February 09, 2024 Shares of Cloudflare, Inc. (NYSE: NET) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday February 09, 2024 It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session February 08, 2024 Via Benzinga AI-Focused Drug Discovery Stocks Index Up 26% In December December 29, 2023 With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. Via Talk Markets AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week December 17, 2023 A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November December 06, 2023 The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.